The Motley Fool

Why Experian plc, Centrica PLC And Scancell Holdings plc Should Lag The FTSE 100 Today

The FTSE 100 (FTSEINDICES: ^FTSE) is looking positive today on the back of US markets reaching new highs yesterday, with the index of top UK stocks up 31 points to 6,574 approaching midday. If this keeps up, we’ll be looking at another positive week, with the FTSE so far up 199 points since last Friday’s close.

But which companies are not keeping up with it? Here are three from the FTSE indices that are slipping back today:

5G is here – and shares of this ‘sleeping giant’ could be a great way for you to potentially profit!

According to one leading industry firm, the 5G boom could create a global industry worth US$12.3 TRILLION out of thin air…

And if you click here we’ll show you something that could be key to unlocking 5G’s full potential...


Experian shares lost 21p (1.8%) this morning to 1,178p, despite a decent-looking first-quarter update from the credit-rating agency. Overall revenue for the three months to 30 June rose by 7%, with the Latin America region leading the way with a 10% rise. The firm told us that “For the full year, we continue to expect mid-to-high single-digit organic revenue growth, modestly improved margins (at constant currency) and cash flow conversion of at least 90%“.

Despite today’s small fall, Experian shares are still up around 25% over the past year, with a forecast 7% rise in earnings per share putting the shares on a P/E of over 19.


Centrica (LSE: CNA) suffered a minor blip today, dropping 1.4p to 372p, after announcing an acquisition. The firm’s American subsidiary Direct Energy is to buy up Bounce Energy of Texas for $46m. Bounce Energy is a retail supplier of electricity with more than 80,000 residential customers, mainly in its home state.

Today’s fall comes on a mixed day for energy suppliers, with National Grid up a bit and and SSE dipping.


Scancell Holdings (LSE: SCLP), the cancer immunotherapy researcher, suffered a setback today after one of three patients taking part in a higher-dose study of its SCIB1 treatment has had to be excluded after a fault in the equipment delivering the drug. The firm will now try to identify a new patient to continue its search for a “maximally tolerated dose” of SCIB1.

Scancell shares had more then trebled in price over the previous 12 months, before the announcement of a new share issue of £6.5m on annual results day on 9 July sent them plunging to a gain of just 50% over the year.

Finally, reliable dividends can more than compensate for the day-to-day ups and downs of share prices. So how about a company that’s offering a 5% yield and which could be set for some nice share price appreciation too?

It’s the subject of our BRAND-NEW report, “The Motley Fool’s Top Income Share For 2013“, which you can get completely free of charge — but it will only be available for a limited period, so click here to get your copy today.

> Alan does not own any shares mentioned in this article.

“This Stock Could Be Like Buying Amazon in 1997”

I'm sure you'll agree that's quite the statement from Motley Fool Co-Founder Tom Gardner.

But since our US analyst team first recommended shares in this unique tech stock back in 2016, the value has soared.

What's more, we firmly believe there's still plenty of upside in its future. In fact, even throughout the current coronavirus crisis, its performance has been beating Wall St expectations.

And right now, we're giving you a chance to discover exactly what has got our analysts all fired up about this niche industry phenomenon, in our FREE special report, A Top US Share From The Motley Fool.

Click here to claim your copy now — and we’ll tell you the name of this Top US Share… free of charge!

Our 6 'Best Buys Now' Shares

Renowned stock-picker Mark Rogers and his analyst team at The Motley Fool UK have named 6 shares that they believe UK investors should consider buying NOW.

So if you’re looking for more stock ideas to try and best position your portfolio today, then it might be a good day for you. Because we're offering a full 33% off your first year of membership to our flagship share-tipping service, backed by our 'no quibbles' 30-day subscription fee refund guarantee.

Simply click below to discover how you can take advantage of this.